Daily as of 2 Nov 16:00 ET
- Price
- below both $4.00 vs 50 $4.69 / 200 $4.49
- Projection
- 💀Death cross projected in 8 bars
- Test
- No active test
- Last cross
- 🟨Golden cross 8 Jul 2026 · projected 11 bars out · tested 1 bar
ABUS | Arbutus Biopharma CorporationNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$4.00
-$0.21 (-4.99%)
Arbutus Biopharma Corporation (ABUS) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2018.
Right now the daily is the chart to watch. The 50 SMA has sat above the 200 since Jul 2026, but the two have been closing on each other and a death cross is projected within 10 bars. On both the daily and the 4-hour, price sits below the 50 and the 200; on the weekly it is between the two.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- between the two $4.21 vs 50 $4.47 / 200 $3.41
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross week of 30 Sep 2024 · projected 27 bars out
4-hour as of 3 Nov 16:00 ET
- Price
- below both $3.88 vs 50 $4.28 / 200 $4.64
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross 16 Oct 2026 · projected 25 bars out
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 16 Oct 2026 | 💀Death | 4-hour | 25 bars out | Not tested |
| 8 Jul 2026 | 🟨Golden flat | daily | 11 bars out | 1 bar cross test |
| 5 Jun 2026 | 💀Death flat | daily | 9 bars out | 4 bar cross test |
| 3 Jun 2026 | 🟨Golden | 4-hour | 11 bars out | 4 bar cross test |
| 13 Apr 2026 | 💀Death | 4-hour | 13 bars out | 3 bar cross test |
About ABUS
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$16.8M
4-hour coverageYes, since Oct 2025
History on recordSince 2018
SectorHealthcare
Cap bandsmall